Taro Pharmaceutical Industries Ltd. Appoints Professor Dov Pekelman to its Board of Directors Replacing Hasmukh Shah

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (“Taro,” Pink Sheets: TAROF) announced today that Mr. Hasmukh Shah has resigned from Taro’s Board of Directors (“Board”), effective August 22, 2011, due to personal reasons and the vacancy has been filled by the appointment of Professor Dov Pekelman, who will serve until Taro’s next Annual General Meeting of Shareholders.

MORE ON THIS TOPIC